read next
Progesterone After IVF Transfer: What to Expect
Somewhere between retrieval and transfer, your RE will tell you whether your embryos are going back this cycle or getting frozen for later. For most patients this is presented as a clinical decision already made, which leaves them wondering whether the other option would have been better.
The honest answer is that the research is more nuanced than either side of the internet debate suggests. Frozen transfer has become the default at most clinics, and for good reasons. But the largest randomized trial on the subject found no meaningful difference in live birth rates, and a 2025 study suggests fresh transfer may actually be better for one specific group of patients.
Here is what the evidence actually shows, and what it means for your cycle.
"Frozen transfer is not universally better. It is better for specific situations, and those situations happen to describe most IVF patients."
Here is where the major studies actually landed.
| Finding | What the data showed |
|---|---|
| Live birth rate, ovulatory women | The largest randomized trial found no significant difference: 48.7% frozen versus 50.2% fresh. For most patients, the two approaches produce comparable outcomes. |
| Low-prognosis patients | A 2025 trial of 838 women aged 33 to 34 with a low prognosis found fresh transfer produced better live birth rates than frozen in this specific group. |
| High responders | Patients producing large numbers of follicles consistently do better with frozen transfer, largely because very high estradiol impairs lining receptivity. |
| OHSS risk | A freeze-all approach eliminates the risk of a fresh transfer pregnancy worsening OHSS, which is why it is standard for high-risk patients. |
| Neonatal outcomes | Frozen transfers are associated with lower preterm birth rates and higher average birthweights compared to fresh. |
| Genetic testing | PGT requires freezing regardless. Results take 7 to 14 days, which is longer than a fresh transfer window allows. |
If your RE recommends one over the other, ask which of these factors applies to you specifically. The reasoning is usually concrete and worth understanding, and it often comes down to something visible in your monitoring data.
Modern vitrification is a flash-freezing process that prevents ice crystal formation, which was the source of damage in older slow-freeze methods. Survival rates for vitrified blastocysts are consistently above 95% at good labs. An embryo that survives the thaw is not considered compromised relative to a fresh one. Ask your clinic for their specific thaw survival rate; it is a fair question and they should have the number.
A medicated FET cycle typically uses estradiol or an estrogen patch to build the lining, followed by progesterone support once the lining reaches adequate thickness. Some protocols add Lupron beforehand to suppress natural ovulation. There are no stimulation injections, which most patients find considerably easier than a retrieval cycle.
Natural-cycle FET protocols use minimal medication and time the transfer to your own ovulation instead. Your RE will choose based on how regular your cycles are.
Embryos are stored in liquid nitrogen at temperatures where biological activity effectively stops. There is no established expiration point, and pregnancies have resulted from embryos stored for well over a decade. Storage duration itself has not been shown to affect thaw survival or live birth rates. The practical considerations are your clinic's storage fees and their consent renewal requirements, not embryo viability.
A fresh transfer typically uses one embryo. Any remaining blastocysts are vitrified and stored for future transfers. This means a fresh transfer cycle is not an either-or decision; you get a fresh attempt and banked frozen embryos from the same retrieval. If the fresh transfer does not result in pregnancy, your next attempt is a frozen transfer without another retrieval.
A freeze-all approach adds vitrification fees, storage fees, and the cost of a separate transfer cycle including its medications. A fresh transfer avoids those but a failed fresh transfer means the next attempt is a frozen one anyway. Cumulative cost across a full course of treatment often ends up comparable. Our IVF cost guide covers the full picture, and you can request a free medication price quote for either protocol before you commit.
A retrieval cycle and a frozen transfer cycle need different medications on different timelines. A freeze-all approach means two separate medication phases weeks apart, and the second one arrives when the urgency of retrieval has passed and it is easy to be caught unprepared.
Prima ships both phases on your clinic's schedule. When your FET protocol is written, we handle insurance verification and prior authorization for the estrogen and progesterone before your lining check, not after. Read our guide to progesterone support after transfer for what the second phase actually involves.
There is no single right answer here, only the right answer for your embryos, your lining, and your risk profile. If your clinic has made a recommendation, ask them which specific factor drove it. The reasoning is almost always something you can see in your own numbers.
Call or text us: (718) 230-3535, open 7 days a week
Clinical Note
Study findings referenced in this post are drawn from a New England Journal of Medicine randomized trial of fresh versus frozen transfer in ovulatory women, a 2025 BMJ-published trial on low-prognosis patients, an NCBI cohort study on advanced maternal age outcomes, and clinical reviews published through April 2026. Individual outcomes vary substantially based on age, embryo quality, uterine factors, and clinic protocol. This content is educational and does not constitute medical advice. Discuss your specific transfer strategy with your reproductive endocrinologist.